TARGEGEN, INC.
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 26, 2013 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 337 Total Citation Count
- Oct 02, 2003 Earliest Filing
- 14 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0252,988 COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSISAbandonedMay 06, 13Sep 26, 13[A61K]
2011/0243,999 METHODS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERSAbandonedApr 04, 11Oct 06, 11[A61K, A61P]
2011/0166,149 PTERIDINE DERIVATIVES FOR TREATING RESPIRATORY DISEASEAbandonedFeb 06, 09Jul 07, 11[A61K, A61P]
2010/0278,811 VASCULOSTATIC AGENTS AND METHODS OF USE THEREOFAbandonedDec 01, 09Nov 04, 10[A61K, A61P]
2007/0161,645 Thiazole inhibitors targeting resistant kinase mutationsAbandonedOct 31, 06Jul 12, 07[A61K, C07D]
2007/0149,508 Six membered heteroaromatic inhibitors targeting resistant kinase mutationsAbandonedOct 31, 06Jun 28, 07[A61K, C07D]
2006/0292,203 Methods and compositions for the treatment of ocular disordersAbandonedJun 07, 06Dec 28, 06[A61K, A61F]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
